mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
BRD-K71781559 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.6 |
mRNA |
betulinic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ZSTK474 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
isonicotinohydroxamic acid |
CTRPv2 |
pan-cancer |
AAC |
-0.024 |
0.6 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.027 |
0.6 |